Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.

PloS one - 1 Jan 2018

Quebrada Palacio Luz P, González Mariela N, Hernandez-Vasquez Yolanda, Perrone Alina E, Parodi-Talice Adriana, Bua Jacqueline, Postan Miriam

Abstract excerpt

Trypanosoma cruzi is a genetically heterogeneous group of organisms that cause Chagas disease. It has been long suspected that the clinical outcome of the disease and response to therapeutic agents are, at least in part, related to the genetic characteristics of the parasite. Herein, we sought to validate the significance of the genotype of T. cruzi isolates recovered from patients with different clinical forms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Argentina
Share to Chagas Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chlorocebus aethiops

Share to Drug Resistance

Share to Protozoan Proteins

Share to Trypanocidal Agents

Share to Trypanosoma cruzi

Share to Vero Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 30183775
DOI: 10.1371/journal.pone.0203462
PMCID: PMC6124804

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic diversity and drug susceptibility of Trypanosoma cruzi TcV clinical isolates.PMID 30183775Read ↗

Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.Semantic proximity Read ↗

In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: A systematic review and meta-analysis.Semantic proximity Read ↗

In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma cruzi Strains Belonging to Discrete Typing Units TcI, TcII, and TcVSemantic proximity Read ↗

Trypanosoma cruzi DTU diversity, benznidazole response, and clinical manifestations of Chagas disease: a seventeen-year systematic review and meta-analysis.Semantic proximity Read ↗

In Vitro Benznidazole and Nifurtimox Susceptibility Profile of <em>Trypanosoma cruzi</em> Strains Belonging to Discrete Typing Units TcI, TcII and TcVSemantic proximity Read ↗

In vitro susceptibility to benznidazole, nifurtimox and posaconazole of Trypanosoma cruzi isolates from ParaguaySemantic proximity Read ↗

Genetic Characterization of Trypanosoma cruzi I Populations from an Oral Chagas Disease Outbreak in Venezuela: Natural Resistance to Nitroheterocyclic Drugs.Semantic proximity Read ↗

Molecular Characterization of Four Mexican Isolates of Trypanosoma cruzi and Their Profile Susceptibility to Nifurtimox.Semantic proximity Read ↗

Fifteen Years after the Definition of <em>Trypanosoma cruzi </em>DTUs: What Have We Learned?Semantic proximity Read ↗

New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes.Semantic proximity Read ↗

Biological characterization of Trypanosoma cruzi strains.Semantic proximity Read ↗

Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.